Surgery Partners, Inc. (SGRY) Tops Q2 EPS by 1c ; Offers Guidance

Surgery Partners, Inc. (NASDAQ: SGRY) reported Q2 EPS of $0.17, $0.01 better than the analyst estimate of $0.16. Revenue for the quarter came in at $826.2 million versus the consensus estimate of $819.45 million.

GUIDANCE:

Surgery Partners, Inc. sees FY2025 revenue of $3.3-3.45 billion, versus the consensus of $3.37 billion.

For earnings history and earnings-related data on Surgery Partners, Inc. (SGRY) click here.

You May Also Be Interested In

• Morgan Stanley upgrades CDW on stronger AI-driven server demand
• Pelican Way Research shorts Hyliion Holdings (HYLN) on VFG deal concerns
• Zeta Surgical begins TMS navigation treatments at Hope Therapeutics clinics